Fundz

Gilgamesh Pharmaceuticals, Inc. reported raising $34.7 Million in an initial SEC Form D filing, from an offering of $34.7 Million

PRIVATEMay 06, 2021$34.7M of $34.7M raised

Amount Raised

$34.7 Million

$34.7 Million sold, per SEC Form D (first sale May 6, 2021)

Round Type

Venture

New YorkHealthcare

Who else raised in Healthcare around the same time

Companies in the same sectors as Gilgamesh Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Cedar raised $268M on June 17, 2021.
  • Korsana Biosciences raised $18M on June 17, 2021.
  • PanTher Therapeutics raised $5.4M (Series A) on June 17, 2021.
  • Circle Pharma raised $66M (Series C) on June 17, 2021.
  • Tridiuum, Inc. raised $6M on June 17, 2021.
  • Rx Redefined raised $3.2M (Seed) on June 16, 2021.

Who to call at Gilgamesh Pharmaceuticals, and when

A new round usually means Gilgamesh Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Gilgamesh Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gilgamesh Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gilgamesh Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Gilgamesh Pharmaceuticals

Location

113 University Place

New York, New York, United States

About

Gilgamesh is a pioneering, mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions. For more information, visit: www.gilgameshpharmaceutical.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Gilgamesh Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsEric, VP, Toxicology and ADME hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Gilgamesh Pharmaceuticals's next move

See what Strategic adds

Gilgamesh Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.